145 results on '"Saravia, Nancy G."'
Search Results
2. Clonal Diversity in the Expression and Stability of the Metastatic Capability of Leishmania guyanensis in the Golden Hamster
3. Sensitivity to Glucantime® of Leishmania viannia Isolated from Patients Prior to Treatment
4. Permissiveness of Human Monocytes and Monocyte-Derived Macrophages to Infection by Promastigotes of Leishmania (Viannia) panamensis
5. Treponema pallidum Elicits Innate and Adaptive Cellular Immune Responses in Skin and Blood during Secondary Syphilis: A Flow-Cytometric Analysis
6. Pharmacokinetics of Antimony in Children Treated for Leishmaniasis with Meglumine Antimoniate
7. Resistance to Oxidative Stress Is Associated with Metastasis in Mucocutaneous Leishmaniasis
8. Resistance to Antimony and Treatment Failure in Human Leishmania (Viannia) Infection
9. Selective Action of Fluoroquinolones against Intracellular Amastigotes of Leishmania (Viannia) panamensis In vitro
10. Infectivity of Trypanosoma rangeli in a Promonocytic Mammalian Cell Line
11. Metastatic Capability of Leishmania (Viannia) panamensis and Leishmania (Viannia) guyanensis in Golden Hamsters
12. Behavior of Leishmania braziliensis s.l. in Golden Hamsters: Evolution of the Infection under Different Experimental Conditions
13. Advances in leishmaniasis
14. Social innovation in global health: sparking location action
15. Concurrent Mucosal Leishmaniasis and Pulmonary Tuberculosis
16. Polymorphisms in cg2 and pfcrt genes and resistance to chloroquine and other antimalarials in vitro in Plasmodium falciparum isolates from Colombia
17. Recurrent lesions in human Leishmania braziliensis infection-reactivation or reinfection?
18. Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility
19. Epidemiology of Cutaneous Leishmaniasis in Colombia: A Longitudinal Study of the Natural History, Prevalence, and Incidence of Infection and Clinical Manifestations
20. Epidemiology of Cutaneous Leishmaniasis in Colombia: Environmental and Behavioral Risk Factors for Infection, Clinical Manifestations, and Pathogenicity
21. An Innovative Field-Applicable Molecular Test to Diagnose Cutaneous Leishmania Viannia spp. Infections
22. Parasitological Confirmation and Analysis of Leishmania Diversity in Asymptomatic and Subclinical Infection following Resolution of Cutaneous Leishmaniasis
23. The association of serum proteins with peripheral blood cells at low ionic strength: Ultrastructural examination
24. Human Macrophage Response to L. (Viannia) panamensis: Microarray Evidence for an Early Inflammatory Response
25. Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis
26. Leishmania (Viannia) Infection in the Domestic Dog in Chaparral, Colombia
27. Murine model of chronic L. (Viannia) panamensis infection: Role of IL-13 in disease
28. Antimony Resistance and Trypanothione in Experimentally Selected and Clinical Strains of Leishmania panamensis
29. Etiologic Agent of an Epidemic of Cutaneous Leishmaniasis in Tolima, Colombia
30. Treponema pallidumElicits Innate and Adaptive Cellular Immune Responses in Skin and Blood during Secondary Syphilis: A Flow‐Cytometric Analysis
31. Resistance to Antimony and Treatment Failure in HumanLeishmania (Viannia)Infection
32. Comparative protein profiling identifies elongation factor-1β and tryparedoxin peroxidase as factors associated with metastasis in Leishmania guyanensis
33. Role of the ABC Transporter MRPA (PGPA) in Antimony Resistance in Leishmania infantum Axenic and Intracellular Amastigotes
34. AMPLIFICATION OF HUMAN DNA BY PRIMERS TARGETED TO LEISHMANIA KINETOPLAST DNA AND POST-GENOME CONSIDERATIONS IN THE DETECTION OF PARASITES BY A POLYMERASE CHAIN REACTION
35. INHIBITION OF LEISHMANIA DONOVANI PROMASTIGOTE DNA TOPOISOMERASE I AND HUMAN MONOCYTE DNA TOPOISOMERASES I AND II BY ANTIMONIAL DRUGS AND CLASSICAL ANTITOPOISOMERASE AGENTS
36. Antimony Uptake Systems in the Protozoan Parasite Leishmania and Accumulation Differences in Antimony-Resistant Parasites
37. Mapa del proteoma de parásitos de Leishmania Viannia a partir de electroforesis de geles de poliacramida en dos dimensiones y otras técnicas asociadas
38. Eficacia de amodiaquina y sulfadoxina/pirimetamina en el tratamiento de malaria no complicada por Plasmodium falciparum en Nariño, Colombia, 1999-2002.
39. Establishing two-dimensional gels for the analysis of Leishmania proteomes
40. Performance of OptiMAL® in the diagnosis of Plasmodium vivax and Plasmodium falciparum infections in a malaria referral center in Colombia
41. Gender Is a Major Determinant of the Clinical Evolution and Immune Response in Hamsters Infected withLeishmaniaspp
42. INTRASPECIFIC HETEROGENEITY IN THE MINI-EXON GENE LOCALIZATION OFLEISHMANIA(VIANNIA)PANAMENSISANDLEISHMANIA(VIANNIA)GUYANENSISFROM COLOMBIA
43. Sensitivity of Leishmania viannia panamensis to Pentavalent Antimony Is Correlated with the Formation of Cleavable DNA-Protein Complexes
44. In Situ Characterization of the Human Host Response to Leishmania panamensis
45. Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: re-examination of haematogenous dissemination
46. Correlation between Histopathology, Immune Response, Clinical Presentation, and Evolution in Leishmania braziliensis Infection
47. Leishmanin Skin Test Standardization and Evaluation of Safety, Dose, Storage, Longevity of Reaction and Sensitization
48. Mucosal Disease Caused by Leishmania Braziliensis Guyanensis
49. Role of the ABC Transporter MRPA (PGPA) in Antimony Resistance in Leishmania infantumAxenic and Intracellular Amastigotes
50. Antimony Uptake Systems in the Protozoan Parasite Leishmaniaand Accumulation Differences in Antimony-Resistant Parasites
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.